HOME >> BIOLOGY >> NEWS
Institute for OneWorld Health nominated for the 2004 World Technology Awards

San Francisco, Calif. Aug. 16, 2004 The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., announced today that it has been nominated for this year's World Technology Awards in the category of Health & Medicine. The award is sponsored by the World Technology Network (WTN) and held in association with Nasdaq, Microsoft, TIME magazine, Science magazine, and CNN.

Nominees for the World Technology Awards are selected by their peers in recognition of innovative work that is deemed likely to have long-term significance. The 20 award categories range from biotechnology, space and energy to ethics, design and entertainment. Winners will be announced on Oct. 8 at the World Technology Awards gala ceremony at San Francisco City Hall following the two-day World Technology Summit, which brings together more than 700 WTN members representing more than 55 countries.

"We are honored to be recognized so highly for our work in drug development to address global health inequities," stated Victoria Hale, Ph.D., Founder and CEO of OneWorld Health. "We are gratified by the confidence our peers have in our ability to deliver on our goal to provide affordable new medicines for people in the developing world." OneWorld Health is in the final stages of a clinical trial to develop a new cure for visceral leishmaniasis (VL), a parasitic disease that kills approximately 200,000 people each year, mostly in the Indian subcontinent. The company will seek regulatory approval in India next year, and finalize distribution plans to make the drug, paromomycin, an affordable, safe therapy to cure VL.

The Institute for OneWorld Health, the first U.S. nonprofit pharmaceutical company develops new, affordable medicines for infectious diseases that disproportionately affect people in the developing world. OneWorld Health applies its entrepreneurial business model with a staff of experienced pharmaceutical scientists who identifies
'"/>

Contact: Joanne Hasegawa
jhasegawa@oneworldhealth.org
415-421-4700
Institute for OneWorld Health
16-Aug-2004


Page: 1 2

Related biology news :

1. NIH awards $18.2m to The Burnham Institute to develop Center on Proteolytic Pathways
2. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
3. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
4. UNC researchers awarded $8.65 million from National Institute on Aging
5. Institute for OneWorld Health receives Gates Foundation grant
6. Lupus Research Institute awards $3 million in novel research grants to further new science in lupus
7. Virginia Bioinformatics Institute researcher advances fight against sudden oak death disease
8. Institute for OneWorld Health CEO to speak at BIO on leveraging opportunities for global health
9. Institute for OneWorld Health CEO advocates focus first on developing world markets
10. Institute for Systems Biology, Pacific Northwest National Laboratory announce collaboration
11. Harvard Stem Cell Institute hosts inaugural symposia

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... , ... September 30, 2019 ... ... disrupter and leading supplier of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing ... product formulations related to “Ready-to-Print” (RTP) cellular product formats (patent number AU ...
(Date:9/25/2019)... ... September 25, 2019 , ... ... collaboration and dialogue, today announces its inaugural South CEO conference to ... Louisiana. , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives ...
(Date:9/24/2019)... ... September 24, 2019 , ... A-Alpha Bio , ... development, announced today that it has raised $2.8M from leading science-focused venture capital ... includes AME Cloud Ventures, Boom Capital, Madrona Venture Group, Sahsen Ventures, Washington Research ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, ... to announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art ... new facility demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... Drug resistance has been declared as ... Organization, with MRSA becoming one of the most serious concerns. Hong Kong cannot be ... of community-associated MRSA (CA-MRSA), or a seven-fold of the figure in 2007 – the ...
(Date:9/24/2019)... RAPID CITY, S.D. (PRWEB) , ... September 24, 2019 , ... ... million in funding for research led by faculty at South Dakota School of ... focuses on the tiny microbes that attach to surfaces to form a slimy and ...
(Date:9/17/2019)... ... 2019 , ... Geneticure, Inc., a Rochester Minnesota company developing ... U.S. Patent and Trademark Office (USPTO) and European Patent Office (EPO) have issued ... hypertension treatment. , The patent applies to Geneticure’s first pharmacogenomics test, in ...
Breaking Biology Technology:
Cached News: